DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS
Clinical trials for DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS trials appear
Sign up with your email to follow new studies for DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New TB drug combo shows promise in phase 2 trial
Disease control Recruiting nowThis study tests whether a new drug called TBD09, when used with other TB medicines, is safe and works well for adults with drug-sensitive tuberculosis. About 150 people will take part. The goal is to see how quickly the drug combination kills TB bacteria and if it causes any sid…
Matched conditions: DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS
Phase: PHASE2 • Sponsor: Gates Medical Research Institute • Aim: Disease control
Last updated May 26, 2026 12:01 UTC
-
New TB cocktail aims to clear lungs faster
Disease control Recruiting nowThis study tests whether adding nicotinamide (a form of vitamin B3) to a three-drug regimen can safely and quickly clear tuberculosis bacteria from the lungs. About 165 adults with drug-susceptible TB will receive either the standard treatment or the new combination. The goal is …
Matched conditions: DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS
Phase: PHASE2 • Sponsor: Gates Medical Research Institute • Aim: Disease control
Last updated May 22, 2026 13:52 UTC